Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net loss	$ (11,964)	$ (25,937)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,020	3,439
Operating lease right-of-use assets expense	4,975	5,294
Foreign currency remeasurement loss	1,212	763
Stock-based compensation	29,807	26,975
Deferred income taxes	(235)	(240)
Other	(4)	725
Change in value of earn-out and warrant liabilities	11,717	6,921
Changes in operating assets and liabilities:
Accounts receivable	6,873	(4,633)
Prepaid expenses and other current assets	1,767	1,663
Deferred contract costs and other assets	(3,280)	(5,637)
Accounts payable, accrued expenses, operating lease liabilities and other liabilities	(598)	(5,331)
Deferred revenue	11,844	9,282
Net cash provided by operating activities	56,134	13,284
Investing activities
Maturities of investments	5,361	1,292
Purchases of investments	(1,850)	(2,050)
Capitalization of internal-use software	(947)	(988)
Purchase of property and equipment	(2,303)	(1,478)
Issuance of notes receivables	(1,500)	(1,000)
Other investing activities	(130)	0
Net cash used in investing activities	(1,369)	(4,224)
Financing activities
Repurchase of common stock	(21,704)	(33,644)
Proceeds from stock option exercises	3,613	3,865
Redemption of redeemable noncontrolling interest	(6,130)	0
Purchase of public warrants	(3,991)	0
Repayments of finance leases	(6)	(30)
Net cash used in financing activities	(28,218)	(29,809)
Effect of exchange rates on cash	94	(653)
Net increase (decrease) in cash and cash equivalents	26,641	(21,402)
Cash and cash equivalents at beginning of period	223,162	227,188
Cash and cash equivalents at end of period	249,803	205,786
Supplemental disclosures of cash flow information
Income taxes paid	$ 5,552	$ 5,794